CoChat

New‐onset diabetes after liver transplantation and its impact on complications and patient survival: 肝移植后的新发糖尿病及其对并发症和预后的影响

Lv, Chaoyang, Zhang, Yao, Chen, Xianying, Huang, Xiaowu, Xue, Mengjuan, Sun, Qiman, Wang, Ting, Liang, Jing, He, Shunmei, Gao, Jian, Zhou, Jian, Yu, Mingxiang, Fan, Jia, Gao, Xin · 2015 · Journal of Diabetes
Cited by 69

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: The aim of the present study was to investigate the incidence and risk factors of new‐onset diabetes after transplantation (NODAT) in liver transplant recipients and the influence of NODAT on complications and long‐term patient survival. Methods: We examined 438 patients who underwent liver transplantation between A pril 2001 and D ecember 2008 and were not diabetic before transplantation. Results: The mean (± SD) follow‐up duration was 2.46 ± 1.62 years. The incidence of NODAT 3, 6, 9, 12, 36, and 60 months after transplantation was 44.24%, 25.59%, 23.08%, 25.17%, 17.86%, and 18.18%, respectively. Multifactor analysis indicated that preoperative fasting plasma glucose (FPG) levels and donor liver steatosis were independent risk factors for NODAT, whereas administration of an interleukin‐2 receptor (IL‐2R) antagonist reduced the risk of NODAT. Compared with the no NODAT group (N‐NODAT), the NODAT group had a higher rate of sepsis and chronic renal insufficiency. Mean survival was significantly longer in the N‐NODAT than NODAT group. Cox regression analysis showed that pre‐ and/or postoperative FPG levels, tumor recurrence or metastasis, and renal insufficiency after liver transplantation were independent risk factors of mortality. Pulmonary infection or multisystem failure were specific causes of death in the NODAT group, whereas patients in both groups died primarily from tumor relapse or metastasis. Conclusions: Preoperative FPG levels and donor liver steatosis were independent risk factors for NODAT, whereas administration of an IL‐2R antagonist reduced the risk of NODAT. Patients with NODAT had reduced survival and an increased incidence of sepsis and chronic renal insufficiency. Significant causes of death in the NODAT group were pulmonary infection and multisystem failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1753-0407.12275

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 69

Metadata

Authors
Lv, C., Zhang, Y., Chen, X., Huang, X., Xue, M., Sun, Q., Wang, T., Liang, J., He, S., Gao, J., Zhou, J., Yu, M., Fan, J., & Gao, X.
Venue
Journal of Diabetes
Publisher
Wiley
Published
2015-03-24
Volume
7
Issue
6
Pages
881-890
ISSN
  • 1753-0393 (ISSN-L)
  • 1753-0407
OpenAlex
W1570119496
Cited by
69
References
5
FWCI
6.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New‐onset diabetes after liver transplantation and its impact on complications and patient survival: 肝移植后的新发糖尿病及其对并发症和预后的影响. https://app.cochat.ai/papers/10.1111/1753-0407.12275
The paper
Lv, C., Zhang, Y., Chen, X., Huang, X., Xue, M., Sun, Q., Wang, T., Liang, J., He, S., Gao, J., Zhou, J., Yu, M., Fan, J., & Gao, X. (2015). New‐onset diabetes after liver transplantation and its impact on complications and patient survival: 肝移植后的新发糖尿病及其对并发症和预后的影响. Journal of Diabetes. https://doi.org/10.1111/1753-0407.12275

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.